FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220667600> ?p ?o ?g. }

• W4220667600 endingPage "378" @default.
• W4220667600 startingPage "367" @default.
• W4220667600 abstract "Most high-grade ovarian carcinomas (HGOCs) are sensitive to carboplatin (CBP)-based chemotherapy but frequently recur within 24 months. Recurrent tumors remain CBP-sensitive and acquire resistance only after several treatment rounds. Recurrences arise from a small number of residual tumor cells not amenable to investigation in patients. We developed patient-derived xenografts (PDXs) that allow the study of these different stages of CBP-sensitive recurrence and acquisition of resistance. We generated PDX models from CBP-sensitive and intrinsically resistant HGOC. PDXs were CBP- or mock-treated and tumors were sampled, after treatment and at recurrence. We also isolated models with acquired-resistance from CBP-sensitive PDXs. Tumors were characterized at the histological and transcriptome levels. PDX models reproduced treatment response seen in the patients. CBP-sensitive residual tumors contained nonproliferating tumor cell clusters embedded in a fibrotic mesh. In nontreated PDX tumors and treated CBP-resistant tumors, fibrotic tissue was not prevalent. Residual tumors had marked differences in gene expression when compared to naïve and recurrent tumors, indicating downregulation of the cell cycle and proliferation and upregulation of interferon response and the epithelial-mesenchymal transition. This gene expression pattern resembled that described in embryonal diapause and 'drug-tolerant persister' states. Residual and acquired-resistance tumors share the overexpression of three genes: CEACAM6, CRYAB, and SOX2. Immunostaining analysis showed strong CEACAM6, CRYAB, and SOX2 protein expression in CBP-sensitive residual and acquired-resistance PDX, thus confirming the RNA profiling results. In HGOC PDX, CBP-sensitive recurrences arise from a small population of quiescent, drug-tolerant, residual cells embedded in a fibrotic mesh. These cells overexpress CEACAM6, CRYAB, and SOX2, whose overexpression is also associated with acquired resistance and poor patient prognosis. CEACAM6, CRYAB, and SOX2 may thus serve as a biomarker to predict recurrence and emergence of resistant disease in CBP-treated HGOC patients. © 2022 The Pathological Society of Great Britain and Ireland." @default.
• W4220667600 created "2022-04-03" @default.
• W4220667600 creator A5000921685 @default.
• W4220667600 creator A5019839327 @default.
• W4220667600 creator A5021661270 @default.
• W4220667600 creator A5035202401 @default.
• W4220667600 creator A5045326986 @default.
• W4220667600 creator A5050910362 @default.
• W4220667600 creator A5053668514 @default.
• W4220667600 creator A5060768772 @default.
• W4220667600 creator A5064409138 @default.
• W4220667600 date "2022-04-20" @default.
• W4220667600 modified "2023-10-13" @default.
• W4220667600 title "In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress <scp>CRYAB</scp> , <scp>CEACAM6,</scp> and <scp>SOX2</scp>" @default.
• W4220667600 cites W1781764024 @default.
• W4220667600 cites W1845067222 @default.
• W4220667600 cites W2002650640 @default.
• W4220667600 cites W2004144597 @default.
• W4220667600 cites W2055091294 @default.
• W4220667600 cites W2055502077 @default.
• W4220667600 cites W2079484912 @default.
• W4220667600 cites W2085934079 @default.
• W4220667600 cites W2098493786 @default.
• W4220667600 cites W2107062469 @default.
• W4220667600 cites W2117895812 @default.
• W4220667600 cites W2130410032 @default.
• W4220667600 cites W2131593373 @default.
• W4220667600 cites W2141037581 @default.
• W4220667600 cites W2146967368 @default.
• W4220667600 cites W2146968962 @default.
• W4220667600 cites W2151628822 @default.
• W4220667600 cites W2165836181 @default.
• W4220667600 cites W2185596862 @default.
• W4220667600 cites W2223385340 @default.
• W4220667600 cites W2315350166 @default.
• W4220667600 cites W2345356016 @default.
• W4220667600 cites W2541723061 @default.
• W4220667600 cites W2553053943 @default.
• W4220667600 cites W2560138732 @default.
• W4220667600 cites W2586556497 @default.
• W4220667600 cites W2749898086 @default.
• W4220667600 cites W2761383206 @default.
• W4220667600 cites W2768564401 @default.
• W4220667600 cites W2792780338 @default.
• W4220667600 cites W2901068426 @default.
• W4220667600 cites W2901323504 @default.
• W4220667600 cites W2901570052 @default.
• W4220667600 cites W2909932177 @default.
• W4220667600 cites W2947400018 @default.
• W4220667600 cites W2952102703 @default.
• W4220667600 cites W2952481429 @default.
• W4220667600 cites W2973117635 @default.
• W4220667600 cites W3013087348 @default.
• W4220667600 cites W3040825500 @default.
• W4220667600 cites W3081300854 @default.
• W4220667600 cites W3096521890 @default.
• W4220667600 cites W3101779884 @default.
• W4220667600 cites W3113156128 @default.
• W4220667600 cites W3114417873 @default.
• W4220667600 cites W3119368021 @default.
• W4220667600 cites W3120564033 @default.
• W4220667600 cites W3120587938 @default.
• W4220667600 cites W3129745115 @default.
• W4220667600 cites W3132120461 @default.
• W4220667600 cites W3134602318 @default.
• W4220667600 cites W3152880902 @default.
• W4220667600 doi "https://doi.org/10.1002/path.5896" @default.
• W4220667600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35302657" @default.
• W4220667600 hasPublicationYear "2022" @default.
• W4220667600 type Work @default.
• W4220667600 citedByCount "5" @default.
• W4220667600 countsByYear W42206676002023 @default.
• W4220667600 crossrefType "journal-article" @default.
• W4220667600 hasAuthorship W4220667600A5000921685 @default.
• W4220667600 hasAuthorship W4220667600A5019839327 @default.
• W4220667600 hasAuthorship W4220667600A5021661270 @default.
• W4220667600 hasAuthorship W4220667600A5035202401 @default.
• W4220667600 hasAuthorship W4220667600A5045326986 @default.
• W4220667600 hasAuthorship W4220667600A5050910362 @default.
• W4220667600 hasAuthorship W4220667600A5053668514 @default.
• W4220667600 hasAuthorship W4220667600A5060768772 @default.
• W4220667600 hasAuthorship W4220667600A5064409138 @default.
• W4220667600 hasBestOaLocation W42206676002 @default.
• W4220667600 hasConcept C104317684 @default.
• W4220667600 hasConcept C121608353 @default.
• W4220667600 hasConcept C127561419 @default.
• W4220667600 hasConcept C142724271 @default.
• W4220667600 hasConcept C2776694085 @default.
• W4220667600 hasConcept C2777933648 @default.
• W4220667600 hasConcept C2778239845 @default.
• W4220667600 hasConcept C2780427987 @default.
• W4220667600 hasConcept C2781451048 @default.
• W4220667600 hasConcept C2908647359 @default.
• W4220667600 hasConcept C502942594 @default.
• W4220667600 hasConcept C54355233 @default.
• W4220667600 hasConcept C55493867 @default.
• W4220667600 hasConcept C71924100 @default.
• W4220667600 hasConcept C86339819 @default.

• next